News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tolero Pharmaceuticals Highlights Alvocidib Data To Be Presented At The American Society of Clinical Oncology Annual Meeting


5/15/2014 9:52:31 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Tolero Pharmaceuticals, Inc., a clinical-stage company developing treatments for serious hematological diseases, today announced the upcoming presentation of data from recent Phase 2 clinical studies of Alvocidib at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from May 30th thru June 3rd.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES